CaliberCos gets Nasdaq bid-price deficiency notice; 180-day cure window through Feb 2027

CaliberCos Inc.

• Nasdaq staff notified CaliberCos on Aug 21, 2026 that bid price closed below $1.00 for 33 consecutive business days.
• Company has 180-day grace period through Feb 17, 2027 to regain compliance with Nasdaq Rule 5550(a)(2).
• To cure, Class A common stock must close at or above $1.00 for at least 10 consecutive business days.
• If not cured, may get a second 180-day period if eligible; otherwise delisting with hearing appeal rights.
• Company intends to monitor bid price and consider all options, including a potential reverse stock split.